For the first time in decades, the U.S. Food and Drug Administration has signed off on new antibiotics to fight gonorrhea. The approvals come at a critical moment: The sexually transmitted infection ...
Higher treatment rates were seen for females, individuals aged 10 to 29 years, suburban dwellers, and patients with chlamydia-gonorrhea coinfection. HealthDay News — Across primary care practices, ...
A new type of antibiotic for treatment of urinary tract infections in women could also work against gonorrhea infections, a new study finds. This could put the medication, called gepotidacin, on track ...
GSK (NYSE:GSK) announced on Monday that the U.S. FDA has granted priority review for its marketing application, aimed at expanding the availability of its antibacterial agent gepotidacin for patients ...
Many people never develop symptoms, which makes it easy to pass the infection unknowingly. No. Many people never develop symptoms, especially women. Up to 50% of women may not notice signs at all, ...
A new clinical research study seeks to determine whether a rapid molecular diagnostic test can reliably identify gonorrhea infections that may be successfully treated with a single dose of an older ...
Gonococcal conjunctivitis (GC) is an eye infection caused by the bacterium responsible for gonorrhea. It can be transmitted from the person giving birth to the newborn during vaginal delivery or ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results